Achieve Life Sciences, Inc.

Diagnostics company · Seattle, Washington, United States · Nasdaq: ACHV

Achieve Life Sciences, Inc. is a diagnostics company headquartered in Seattle, Washington, United States. Its shares trade on Nasdaq under the ticker ACHV. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $2.8 million in total, most recently in 2022. It has reported private securities offerings to the US SEC, most recently $19 million sold in a notice filed in 2022.

www.achievelifesciences.comProfile compiled from public records. Is this your company? Request a correction or update

Achieve Life Sciences at a glance

Typediagnostics company
HeadquartersSeattle, Washington, United States
Stock listingNasdaq: ACHV
SEC industryIn Vitro & In Vivo Diagnostic Substances
Employees (per SBIR records)13
SEC CIK949858

What does Achieve Life Sciences do?

US government research funding

2 SBIR/STTR small-business research awards from US health agencies, $2.8 million in total (2021 to 2022). NIH funding came from the National Institute on Drug Abuse.

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $18.9 million sold (2022).

Frequently asked questions about Achieve Life Sciences

Where is Achieve Life Sciences headquartered?

Achieve Life Sciences, Inc. is headquartered in Seattle, Washington, United States.

What does Achieve Life Sciences do?

Achieve Life Sciences, Inc. is a diagnostics company. Its SEC industry classification is In Vitro & In Vivo Diagnostic Substances.

Is Achieve Life Sciences a public company?

Yes. Achieve Life Sciences, Inc. trades on Nasdaq under the ticker ACHV.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.